Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Bakersfield
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Bakersfield, CA

Studies commonly pay $75 to $4,500 per completed study

70 clinical trials are currently recruiting participants within 30 miles of Bakersfield. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

70studies recruiting
7+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Bakersfield right now

Top 25 of 70 recruiting studies, sorted by proximity — each links to its official registry page

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma Phase 3 Interventional 1,524 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07200830)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD Phase 3 Interventional 284 participants sought
Adverum Clinical Site 109 — Bakersfield, California (1.7 mi) · Sponsor: Adverum Biotechnologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07482176)

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Asthma Phase 2 Interventional 540 participants sought
Research Site — Bakersfield, California (1.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06932263)

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Retinitis Pigmentosa Phase 2 Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: jCyte, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06912633)

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Kidney Calculi; Ureteral Calculi N/A Interventional 101 participants sought
Michael G. Oefelein Clinical Trials — Bakersfield, California (1.7 mi) · Sponsor: Avvio Medical
See eligibility & contact on ClinicalTrials.gov (NCT06942949)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

Severe Asthma Phase 3 Interventional 786 participants sought
Research Site 13 — Bakersfield, California (1.7 mi) · Sponsor: Generate Biomedicines
See eligibility & contact on ClinicalTrials.gov (NCT07359846)

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

Stargardt Disease Phase 1, Phase 2 Interventional 18 participants sought
RayTx Clinical Site — Bakersfield, California (1.7 mi) · Sponsor: Ray Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07439887)

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

Dysphotopsia, Posterior Capsule Opacification N/A Observational 120 participants sought
Empire Eye and Laser Center — Bakersfield, California (1.7 mi) · Sponsor: Dr. Daniel H. Chang, MD
See eligibility & contact on ClinicalTrials.gov (NCT07213167)

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma Phase 3 Interventional 284 participants sought
Michael Oefelein Clinical Trials — Bakersfield, California (1.7 mi) · Sponsor: Protara Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07480356)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought
Adventist Health - Bakersfield — Bakersfield, California (1.7 mi) · Sponsor: Agendia
See eligibility & contact on ClinicalTrials.gov (NCT03053193)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer Phase 3 Interventional 4,220 participants sought
Comprehensive Blood & Cancer Center — Bakersfield, California (1.7 mi) · Sponsor: Stemline Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06492616)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05334069)

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Multiple Myeloma Phase 1 Interventional 134 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi) · Sponsor: Oncotherapeutics
See eligibility & contact on ClinicalTrials.gov (NCT03110822)

Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

Burnout, Burnout Syndrome N/A Interventional 203 participants sought
Bakersfield VA Clinic, VA Greater Los Angeles Healthcare System — Bakersfield, California (1.7 mi) · Sponsor: VA Greater Los Angeles Healthcare System
See eligibility & contact on ClinicalTrials.gov (NCT07031245)

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Non-small Cell Lung Cancer Phase 3 Interventional 600 participants sought
CBCC Global Research, Inc. ( Site 0123) — Bakersfield, California (1.7 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06345729)

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Non-Muscle Invasive Bladder Cancer Phase 1, Phase 2 Interventional 32 participants sought
Michael G Oefelein Clinical Trials ( Site 0053) — Bakersfield, California (1.7 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06637423)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase 2 Interventional 240 participants sought
California Retina Consultants (CRC) - Bakersfield Office — Bakersfield, California (1.7 mi) · Sponsor: Apellis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07215390)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

COVID-19 SARS-CoV-2 Infection Phase 3 Interventional 2,330 participants sought
National Institute of Clinical Research - Bakersfield — Bakersfield, California (1.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06679140)

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD) Phase 2 Interventional 324 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi) · Sponsor: ONL Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06659445)
Google-rated

Top-rated research centers in Bakersfield

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Kern Research

★ 5.0
1921 18th St, Bakersfield, CA 93301
(661) 864-7710
"They have been amazing. profound results in battling my wife's alopecia. So thankful for them."
— Dennis Hilken, 5★

Trovare Clinical Research

★ 2.5
3838 San Dimas St Ste A280, Bakersfield, CA 93301
(661) 663-3096
"I went to this company seeking a solution to my medical concern,and hoping to improve the quality of my life,which has been growing worse."
— William Vines, 4★

Comprehensive Blood & Cancer Center (CBCC)

★ 4.1 (201 reviews)
6501 Truxtun Ave, Bakersfield, CA 93309
(661) 322-2206
"This place is amazing! Dr. Shambaugh is thorough and his entire staff is so efficient."
— Su R, 5★

Oncology Research Institute (ORI)

★ 5.0 (1 reviews)
9800 Brimhall Rd Ste 200, Bakersfield, CA 93312
(661) 788-5988

Happy Whole You Wellness Center

★ 4.9
2001 G St, Bakersfield, CA 93301
(661) 337-0216

Centre For Neuro Skills

★ 4.2
5215 Ashe Rd, Bakersfield, CA 93313
(661) 872-3408
"The best place on this planet to help with patient’s recovery from traumatic brain injury."
— Miguel, 5★

Labcorp

★ 3.8
3550 Q St Ste 102, Bakersfield, CA 93301
(661) 323-3353
"Oh my goodness the ladies here are so friendly and make your feel at home, and the ladies so far that have done my blood tests always, you can never …"
— BlooEyez, 5★

Clinical trials in Bakersfield: what's recruiting

The Bakersfield area currently has 70 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Bakersfield, the most active research areas are:

  • Cancer & Oncology12 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing2 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Bakersfield, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Bakersfield

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Bakersfield participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Bakersfield?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Bakersfield safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Bakersfield?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Bakersfield typically complete one or two studies per year.

Paid clinical trials near Bakersfield

Other metros within reach

Visalia, CA2 Santa Clarita, CA2,395 Lancaster, CA100 Santa Barbara, CA97 Oxnard, CA130 Thousand Oaks, CA677 Palmdale, CA124 Los Angeles, CA2,943

More of CA

Long Beach3,341 Torrance3,236 Fullerton3,223 Anaheim3,155 Garden Grove3,152 Pomona3,119 Glendale2,957 Los Angeles2,943 Huntington Beach2,841 Santa Clarita2,395 Hayward2,256 Oakland2,249

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts